Results 41 to 50 of about 1,565,970 (254)

Supplemental Material, Table_S2 - Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database

, 2018
Supplemental Material, Table_S2 for Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database by Yomei Matsuoka, Mamoru Narukawa in Therapeutic Innovation & Regulatory Science
Mamoru Narukawa (5170892), Yomei Matsuoka (5170889)   +1 more
core   +1 more source

A short history of anti-rheumatic therapy - VII. Biological agents

Reumatismo, 2011
The introduction of biological agents has been a major turning-point in the treatment of rheumatic diseases, particularly in rheumatoid arthritis. This review describes the principle milestones that have led, through the knowledge of the structure and ...
B. Gatto, P. Marson, G. Pasero
doaj   +1 more source

Supplemental Material, Table_S3 - Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database

, 2018
Supplemental Material, Table_S3 for Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database by Yomei Matsuoka, Mamoru Narukawa in Therapeutic Innovation & Regulatory Science
Mamoru Narukawa (5170892), Yomei Matsuoka (5170889)   +1 more
core   +1 more source

Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to consider. [PDF]

, 2022
Changes to expert opinion in the use of antirheumatic drugs before and during pregnancy five years after EULAR: points to ...
Chambers, Christina, Levy, Roger A, Förger, Frauke, Götestam Skorpen, Carina, Tincani, Angela, Dolhain, Radboud J E M, Costedoat-Chalumeau, Nathalie, Levy, Roger A., Govoni, Marcello, Dolhain, Radboud J.E.M., Häfeli, Céline, Ramoni, Véronique Laure, Véronique Laure Ramoni, Radboud J E M Dolhain, Marcello Govoni, Christina Chambers, Angela Tincani, Céline Häfeli, Frauke Förger, Carina Götestam Skorpen, Nathalie Costedoat-Chalumeau, Roger A Levy   +21 more
core   +2 more sources

Antirheumatic drugs in pregnancy and lactation

, 2013
Antirheumatic drugs in pregnancy and lactation are increasingly a common clinical dilemma. With the shift towards early, aggressive control of autoimmune diseases and with the advent of newer therapeutic agents, there is a need to understand the effects ...
Poonam Sharma, Alice Malpas, Rita Abdulkader, Tarnya Marshall   +3 more
core   +1 more source

Frailty Predicts Incident Osteoporotic Fractures in Veterans with Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Rheumatoid arthritis (RA) is associated with an increased risk of frailty and osteoporosis, but the relationship between frailty and incident osteoporotic fractures in RA is underexplored. Methods Data were from the Veterans Affairs (VA) Rheumatoid Arthritis Registry. Frailty was measured using the VA Frailty Index (VAFI).
Katherine D. Wysham, Hannah F. Brubeck, Aaron Baraff, Punyasha Roul, Namrata Singh, James S. Andrews, Grant W. Cannon, Gary A. Kunkel, Ted R. Mikuls, Bryant R. England, Dolores M. Shoback, Patricia P. Katz, Jose M. Garcia, Ariela R. Orkaby, Joshua F. Baker   +14 more
wiley   +1 more source

Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline

Frontiers in Medicine
ObjectivesTo assess efficacy of withdrawal or tapering biologic disease-modifying antirheumatic drugs (bDMARDs) vs. maintaining a standard regimen in patients with axial spondyloarthritis (axSpA) to sustain remission.MethodsWe conducted a systematic ...
Hye Sang Park, Petra Díaz del Campo, Maria Nieves Plana, Maria Nieves Plana, Maria Nieves Plana, Jessica Polo y La Borda, Mercedes Guerra-Rodríguez, Mireia Moreno, Mireia Moreno, Juan D. Cañete   +9 more
doaj   +1 more source

From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis

Arthritis Care &Research, EarlyView.
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases encompassing axial and peripheral forms, with up to 20% of patients developing symptoms before age 16. Despite this substantial pediatric burden, treatment options for juvenile‐onset SpA (JSpA), particularly those with axial disease (axJSpA), remain limited.
Pamela F. Weiss, Judith A. Smith, Robert A. Colbert, Erin Treemarcki, Michael H. Weisman, Walter P. Maksymowych, Hermine I. Brunner, for the Childhood Arthritis and Rheumatology Research Alliance, Spondyloarthritis Research and Treatment Network, and Pediatric Rheumatology Collaborative Study Group Advisory Council   +9 more
wiley   +1 more source

Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis [PDF]

The Korean Journal of Internal Medicine
Background/Aims The aim of this study was to compare the short- and long-term retention rates of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) in Korean patients with seropositive rheumatoid arthritis.
Bong-Woo Lee, Jennifer Jooha Lee, Wan-Uk Kim   +2 more
doaj   +1 more source

Clinician and Patient Factors Associated With Long‐Term Glucocorticoid Use in People With Rheumatoid Arthritis Receiving Advanced Therapies

Arthritis Care &Research, EarlyView.
Objective Despite guideline recommendations, long‐term glucocorticoid (GC) use is common in rheumatoid arthritis (RA). We conducted a clinician survey nested within a large registry to identify patient and clinician factors associated with GC use. Methods Clinicians contributing patients to the CorEvitas Rheumatoid Arthritis Registry were surveyed ...
Michael D. George, George Reed, Matthew D. Kearney, Peter F. Cronholm, Kevin Kane, Jeffrey R. Curtis, Dimitrios A. Pappas, Joel M. Kremer   +7 more
wiley   +1 more source